Murata T, Aritake K, Tsubosaka Y, Maruyama T, Nakagawa T, Hori M, Hirai H, Nakamura M, Narumiya S, Urade Y, Ozaki H.

Anti-inflammatory role of PGD2 in acute lung inflammation and therapeutic application of its signal enhancement.

Proc Natl Acad Sci USA, 110(13):5205-10. 2013.

Taketomi Y, Ueno N, Kojima T, Sato H, Murase R, Yamamoto K, Tanaka S, Sakanaka M, Nakamura M, Nishito Y, Kawana M, Kambe N, Ikeda K, Taguchi R, Nakamizo S, Kabashima K, Gelb MH, Arita M, Yokomizo T, Nakamura M, Watanabe K, Hirai H, Nakamura M, Okayama Y, Ra C, Aritake K, Urade Y, Morimoto K, Sugimoto Y, Shimizu T, Narumiya S, Hara S, Murakami M.

Mast cell maturation is driven via a group III phospholipase A2-prostaglandin D2-DP1 receptor paracrine axis.

Nat Immunol., 14(6):554-63. 2013.

Mizukoshi T, Komori H, Mizuguchi M, Abdelaziz H, Hara T, Higuchi M, Tanaka Y, Ohara Y, Funato N, Fujii M, Nakamura M.

Failure in activation of the canonical NF-κB pathway by human T-cell leukemia virus type 1 Tax in non-hematopoietic cell lines.

Virology, 443(2):226-35. 2013.

Tsukahara T, Ohmine K, Yamamoto C, Uchibori R, Ido H, Teruya T, Urabe M, Mizukami H, Kume A, Nakamura M, Mineno J, Takesako K, Riviere I, Sadelain M, Brentjens R, Ozawa K.

CD19 target-engineered T-cells accumulate at tumor lesions in human B-cell lymphoma xenograft mouse models.

Biochem Biophys Res Commun., 438(1):84-9. 2013.

Takehara Y, Satoh T, Nishizawa A, Saeki K, Nakamura M, Masuzawa M, Kaneda Y, Katayama I, Yokozeki H.

Anti-tumor effects of inactivated Sendai virus particles with an IL-2 gene on angiosarcoma.

Clin Immunol., 149(1):1-10. 2013.